Ohmori H
Gan To Kagaku Ryoho. 1984 Aug;11(8):1557-62.
Intravesical chemotherapy is one of the most effective treatments for superficial bladder tumors. Recent progress in the development of chemotherapeutic agents has provided a variety of compounds of potential benefit for intravesical administration in cases of superficial bladder tumors, including thio-TEPA, MMC, carboquone, adriamycin, FT-207, cytosine arabinoside and bleomycin, and the in therapeutic effectiveness has been reported. We selected adriamycin, because it is considered suitable for intravesical instillation. A 68% effectiveness has been experienced for instillation repeated six to nine times (adriamycin 50 mg/normal saline 30 ml) and side effects occurred in 23% of patients. Intravesical chemotherapy has also been attempted to prevent recurrence after conservative therapy but these modalities still seem to need further study.
膀胱内化疗是浅表性膀胱肿瘤最有效的治疗方法之一。化疗药物开发的最新进展为浅表性膀胱肿瘤膀胱内给药提供了多种可能有益的化合物,包括噻替派、丝裂霉素、卡波醌、阿霉素、替加氟、阿糖胞苷和博来霉素,并且已有治疗有效性的报道。我们选择阿霉素是因为它被认为适合膀胱内灌注。六至九次重复灌注(阿霉素50毫克/生理盐水30毫升)的有效率为68%,23%的患者出现了副作用。膀胱内化疗也已用于尝试预防保守治疗后的复发,但这些方法似乎仍需进一步研究。